Skip to main navigation menu Skip to main content Skip to site footer

An Approach To:

Vol. 20 No. 2 (2022): New Horizons: Innovation in Medicine

Approach to Hyperkalemia

DOI
https://doi.org/10.26443/mjm.v20i2.903
Submitted
May 30, 2021
Published
2022-06-29

Abstract

Hyperkalemia is one of the most common electrolytic disorders encountered in clinical practice. Serum potassium concentration is tightly regulated by cellular transfer via insulin, catecholamines, and acid-base equilibrium and secondarily by the kidney via aldosterone and renal flow. Severe hyperkalemia can result in dangerous and potentially life-threatening manifestations, mainly cardiac in nature. It is therefore crucial for physicians to be able to identify the causes of hyperkalemia and provide appropriate treatment. This approach article provides an overview of potassium homeostasis, diagnostic strategies, and treatment guidelines for patients with mild, moderate, and severe hyperkalemia.  

References

  1. Hunter RW, Bailey MA. Hyperkalemia: pathophysiology, risk factors and consequences. Nephrol Dial Transplant. 2019;34(Suppl 3):iii2-iii11. doi:10.1093/ndt/gfz206
  2. Palmer BF, Clegg DJ. Diagnosis and treatment of hyperkalemia. Cleveland Clinic Journal of Medicine December 2017, 84 (12) 934-942; DOI: https://doi.org/10.3949/ccjm.84a.17056
  3. Fried L, Kovesdy CP, Palmer BF. New options for the management of chronic hyperkalemia. Kidney Int Suppl (2011). 2017 Dec; 7(3): 164–170. doi: 10.1016/j.kisu.2017.09.001
  4. Fumeaux Z. Hyperkaliémie [Hyperkalemia]. Rev Med Suisse. 2007 Mar 7;3(101):574-6, 578. French. PMID: 17436794.
  5. Parham WA, Mehdirad AA, Biermann KM, Fredman CS. Hyperkalemia Revisited. Tex Heart Inst J. 2006; 33(1): 40–47.
  6. Perazella MA. Drug-induced hyperkalemia: old culprits and new offenders. The American Journal of Medicine. Volume 109, Issue 4, 2000. Pages 307-314. ISSN 0002-9343.
  7. https://doi.org/10.1016/S0002-9343(00)00496-4.
  8. Viera AJ, Wouk N. Potassium Disorders: Hypokalemia and Hyperkalemia. Am Fam Physician. 2015 Sep 15;92(6):487-495.
  9. Liamis G, Liberopoulos E, Barkas F, Elisaf M. Diabetes mellitus and electrolyte disorders. World J Clin Cases. 2014;2(10):488-496. doi:10.12998/wjcc.v2.i10.488
  10. Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther. 2012 Jun;30(3):e156-66. doi: 10.1111/j.1755-5922.2010.00258.x. Epub 2011 Jan 26. PMID: 21883995.
  11. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232-5
  12. Aljadhey H, Tu W, Hansen RA, Blalock S, Brater DC, Murray MD. Risk of hyperkalemia associated with selective COX-2 inhibitors. Pharmacoepidemiol Drug Saf. 2010;19(11):1194-1198. doi:10.1002/pds.2011
  13. Horisberger JD, Giebisch G. Potassium-sparing diuretics. Ren Physiol. 1987;10(3-4):198-220. doi: 10.1159/000173130. PMID: 2455308.
  14. Clase CM, Carrero JJ, Ellison DH, et. al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020 Jan;97(1):42-61. doi: 10.1016/j.kint.2019.09.018. Epub 2019 Oct 10. PMID: 31706619
  15. Arnold R, Pianta TJ, Pussell BA, Endre Z, Kiernan MC, Krishnan AV. Potassium control in chronic kidney disease: implications for neuromuscular function. Intern Med J. 2019 Jul;49(7):817-825. doi: 10.1111/imj.14114. PMID: 30230667.
  16. Le T, Bhushan V, Skelley N. First Aid for the USMLE STEP 2 CK. McGraw Hills; 2012.
  17. Diercks DB, Shumaik GM, Harrigan RA, Brady WJ, Chan TC. Electrocardiographic manifestations: electrolyte abnormalities. J Emerg Med. 2004 Aug;27(2):153-60. doi: 10.1016/j.jemermed.2004.04.006.
  18. Flury G. The 'Dangerous' ECG. Praxis. 2019 Jan;108(1):45-52. https://doi/org/10.1024/1661-8157/a003155
  19. Sterns RH, Grieff M, Bernstein PL. Treatment of hyperkalemia: something old, something new. Kidney Int. 2016 Mar;89(3):546-54. doi: 10.1016/j.kint.2015.11.018. Epub 2016 Feb 2. PMID: 26880451.
  20. Mount DB. Treatment and prevention of hyperkalemia in adults. UpToDate; Dec 08, 2020. Available from: http://uptodate.com
  21. Ingelfinger JR. A New Era for the Treatment of Hyperkalemia? N Engl J Med 2015; 372:275-277. DOI: 10.1056/NEJMe1414112

Downloads

Download data is not yet available.